Prescription Dermatology Therapeutics Market Report: Company Analysis, History and Future Overview, Global Sales Trends by 2025

Published Date: 2019-06-20   |   Pages: Ongoing   |   Tables: Ongoing   |  Report ID: 7245

Industry: Life Science

Format : pdf word ppt excel

The global prescription dermatology therapeutics market will grow at a remarkable rate due to the increasing prevalence of chronic diseases such as psoriasis and other dermatological disorders. Introduction of new and innovative products across the globe to treat skin-related disorders is also expected to drive the market. This newly added report provides an unbiased and an in-depth analysis of the report to the clients. The report also offers a company market share analysis to give a wide overview of the prescription dermatology therapeutics market.

Global Prescription Dermatology Therapeutics Market: Drivers and Restraints

Skin is vulnerable to a broad variety of skin toxins and microbes. It is the most and the largest exposed organ of the body. Continuous exposure to toxins results in several kinds of skin diseases such as psoriasis, redness, and acne. Acne treatment is on the most important prescriptions used for improving skin conditions. For instance, psoriasis, a chronic skin disease, is caused by an overactive immune system. Light therapy, oral medications, and steroid creams are mostly used to treat psoriasis diseases.

The market is mainly driven by intensive research to provide therapies for dermatological disorders. Factors such as huge investments in the research and development activities by the pharmaceutical companies, rising urban population affected with the dermatological disorders, efforts taken by key players to provide effective treatments, and the strategic alliances by the companies to enhance the product development are likely to propel the growth of the market in the coming years.

However, the high cost of treatment and stringent government regulations for the approval of the dermatology drugs may create a negative impact on the growth of the prescription dermatology therapeutics market.

Global Prescription Dermatology Therapeutics Market: Forecast by Segments

The prescription dermatology therapeutics market is segmented on the basis of distribution channel and type.

By Distribution

    Mail order pharmacies

    Hospital pharmacies

    Retail pharmacies

The hospital pharmacies segment is expected to dominate the market in the near future due to the rising rate of hospitalization and the high cost of biologic drugs.

By Type

    Skin cancer

    Acne and rosacea drugs

    Fungal infection drugs

    Psoriasis drugs

    Seborrhea drugs


Psoriasis drugs held the largest market share in global market. The segment is expected to continue its dominance over the forecast period.

By Region

North America is likely to hold the largest market share in the global prescription dermatology therapeutics market due to high prevalence of chronic skin diseases and growing adoption of biological drugs for the treatments. Higher awareness as compared to other regions is also expected to boost the growth of this regional market. Asia Pacific is also expected to expand at significant rate due to growing awareness about skin disorders in the emerging economies such as India and China.

Global Prescription Dermatology Therapeutics Market: Key Players

Some of the major players operating in the global prescription dermatology therapeutics market are Aurobindo Pharma Ltd, AbbVie, Inc., Aclaris Therapeutics, Inc., Novartis AG, Sun Pharmaceuticals Ltd., Janssen Biotech, Inc., Bausch Health Companies, Inc., Amgen, Eli Lilly and Company, Celgene Corporation, LEO Pharma A/S, and Pfizer, Inc.

Global Prescription Dermatology Therapeutics Market: Competitive Landscape

Companies are expected to look at mergers and acquisitions as a way forward in the global prescription dermatology therapeutics market. For instance, Aurobindo Pharma Ltd. and Sandoz Inc. have agreed that the former will take over latter’s dermatology and oral solids business. This move will make Aurobindo the second largest players distributing generics in the U.S. by prescriptions. This will also enable diversification of the portfolio, adding about 300 products, which includes the ones under development.

Global Prescription Dermatology Therapeutics Market: Research Methodology

QY Research has used a completely unique research methodology while calculating the market size of to arrive at the projections. The company has given emphasis on using the foolproof model for research. Analysts have used primary and secondary methods to compile the research report. In-depth interviews with the industry experts and several manufacturers were conducted to make the report an exclusive one.

In order to authenticate the data, the research analysts have also interacted with the various members on several panels of the market, across the world who have sufficient knowledge about the particular field. This research report also includes the macro-economic factors like the gross domestic product and Year-on-Year growth forecast to analyze the trajectory of the global market for prescription dermatology therapeutics.

Reasons to Buy this Report

    For exclusive data about the global prescription dermatology therapeutics market in our latest research report.

    For authentic forecasts pertaining to capacity, production, value, consumption, growth rate (CAGR), market share, and milestones so far.

    For valuable insight into manufacturers, capacity, production, revenue, market share, and recent development.

    For identifying significant trends, drivers, influence factors in global, and regions.

NOTE - The analysis, thoughts, views, facts, and opinions expressed in this report are of the respective research analysts. QYR Consulting does not necessarily endorse it or it is also not essentially formal views of QYR Consulting.

Life sciences is a wide branch of study that is gradually becoming an integral industry to the global economics. QYR Consulting looks at the steady transformation of the life sciences industry and its impact on the subindustries such as medical care, pharmaceutical, and medical devices. Our team of esteemed analysts have put together reports to analyze the monumental changes life sciences is expected to bring in the overall healthcare industry. These reports identify the exact turning points for the industry and open up a platform for discussing its growth.

QYR Consulting brings to you a structured analysis of the technological advancements so far, vision of the players in the industry, and the strategies they are likely to use to make their mark. The reports dissect various components of the life sciences industry to scrutinize the influential factors. To help the readers make profitable business decisions, analysts have highlighted the lucrative investment areas and upcoming business opportunities.

Request for Table of Contents

  You must accept our privacy policies before submit your requirement

Request for Table and Figures

  You must accept our privacy policies before submit your requirement

request sample

Intrested in this report ?

Get your Report Sample Now !

Licenses Type

$5400.00   Single License
$7400.00  Multi User License
$9400.00  Corporate License

Intrested in this report ?

Get your
Report Sample Now !

Customize Your Research

Request for data as per your requirement

Get specifications suitable to your business

Receive an in-depth and unique understanding of the subject matter

Acquire insight into specific area of the industry

Stay Ahead of the Competition!

Find out what will be the next key area of growth

Who are the top players?

What are their strategies?

In-depth analysis of future prospects